Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2016 / Apr / Tracing T Cells
Microbiology & Immunology Microbiology and Immunology Technology and innovation Genetics and epigenetics Omics Molecular Pathology

Tracing T Cells

New software can reconstruct T cell receptor sequences from RNA sequencing data, allowing us to track the origins and fates of immune cells

By Michael Schubert 04/22/2016 1 min read

Share

For all that we have learned about the immune system, much of it remains a mystery to us. What goes on behind the scenes in a T cell is a prime example of this – we don’t know how these cells’ fates are determined, nor do we understand the clonal relationship between different T cell types. But a new computational approach (1) from the Wellcome Genome Campus’ Single-Cell Genomics Centre could shed new light on the immune response.

“TraCeR is a software tool that finds and reconstructs the recombined T cell receptor (TCR) sequences that are present within single-cell RNA sequencing data without needing any modifications to the RNA sequencing method,” explains Mike Stubbington, who led the research. This tool allows researchers to do two things: first, they can find the sequence of both chains that comprise the TCR – essential to understanding what antigen that particular TCR can detect. Second, the huge possible diversity of TCR DNA sequences means that cells that share sequences are likely to be “siblings” that derive from the same original progenitor cell. This means that they can now track the family relationships between T cells within a sample. “Crucially, we get the information about TCR sequences in parallel to the RNA-seq gene expression profiles of each cell,” says Stubbington. “This means that we can find out whether all the ‘children’ of a particular T cell do the same thing at the same time, and whether the antigen detected by a T cell can influence its fate choices.” The tool relies on the presence of recombined and expressed DNA sequences that occur naturally within cells of interest – which means that it can be used in B cells as well as T cells, a step the researchers plan to take soon. “This enables us to think about the relationship between T cell specificity and cellular choices. It also allows us to think about how sibling cells make different ‘life choices’ and perform different roles during an immune response.” Unfortunately, the cost of TraCeR is currently prohibitive for routine clinical use, but if technological advances bring the price tag down, it might one day provide useful information about patient responses to vaccination or drug treatment in infectious disease, cancer or autoimmunity.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. MJ Stubbington et al., “T cell fate and clonality inference from single-cell transcriptomes”, Nat Methods, 13, 329–332 (2016). PMID: 26950746.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.